Louis Bograd is a nationally recognized authority on issues of federal preemption, drug and device litigation, and jurisdiction.
He has devoted much of his professional career to litigating appeals on complex issues involving products liability, Medicaid lien reimbursements, constitutional rights, and civil liberties. At Motley Rice, Lou continues his focus on appellate issues and mass torts, further enhancing the firm’s active and growing complex litigation practice. Lou serves as co-chair of the Law & Briefing Committee for the National Prescription Opiate Litigation MDL, which is focused on combatting the alleged deceptive marketing and overdistribution of opioids.
Prior to joining Motley Rice, Lou served as an appellate advocate and Chief Litigation Counsel for the Center for Constitutional Litigation where he led work in mass torts, the Class Action Fairness Act, and dispositive motions concerning consumer protection and products liability. Lou argued for plaintiffs before the U.S. Supreme Court regarding federal preemption of claims against generic drug manufacturers in Pliva, Inc. v. Mensing and has also participated in numerous other Supreme Court cases as counsel for petitioners, respondents, and amici curiae.
Lou has spoken on various legal topics at many seminars, CLE programs, and legal conferences across the country sponsored by, among others, the American Association for Justice, state trial lawyers associations, and Mass Torts Made Perfect. Lou has also presented at judicial education programs sponsored by the Pound Institute, the Brookings Institution, the American Enterprise Institute, the Northwestern University School of Law, and the George Mason University School of Law.
Lou’s legal career began at Arnold & Porter LLP in Washington, D.C., where he managed and directed work on transfusion-associated HIV/AIDS cases on behalf of the American Red Cross. He subsequently served on the American Civil Liberties Union Foundation’s national legal staff and as the legal director of the Alliance for Justice. Lou has also taught advanced torts and products liability law as an Adjunct Professor at the University of Kentucky College of Law.
Selected Publications:
•Louis M. Bograd & Andre M. Mura, Buckman Stops Here! Limits on Preemption of State Tort Claims Involving Allegations of Fraud on the PTO or the FDA, 41 Rutgers L. J. 309 (2009)
•Louis M. Bograd, Be Careful What You Wish For: Drugmakers, the First Amendment, and Preemption, 51TRIAL24 (Nov. 2015)
•Louis M. Bograd, Preemption’s Uncertain Path, 47 TRIAL 20 (Nov. 2011)
•Louis M. Bograd, W(h)ither Preemption?, 45 TRIAL 24 (Nov. 2009)
•Louis M. Bograd, Taking on Big Pharma- and the FDA, 43 TRIAL 30 (Mar. 2007)
Related Content
Recent Blog Posts
May 28, 2019
SCOTUS preemption ruling good news for drug and device plaintiffs
by: Louis M. Bograd
March 27, 2017
An Existential Threat to State Mass Tort Litigation
by: Louis M. Bograd
Related News
February 14, 2020
Law360 names Motley Rice a 2019 Product Liability Practice Group of the Year
January 22, 2020
Motley Rice wins two “Elite Trial Lawyers” Firm of the Year categories
December 10, 2019
2020 “Best Law Firms” ranks Motley Rice
